|
| Leerink analyst predicted Isis stock plummet |
5 May 08, 05:02 |
|
| In the high-stakes game of public biotech investing, it's important to keep track of changes in the regulatory climate at the U.S. Food and Drug Administration -- because any shift in procedure at the powerful agency can have a huge impact on the price of life sciences stocks. |
| more |
|
